Lenalidomide for the treatment of relapsed and refractory multiple myeloma

Lenalidomide is an amino-substituted derivative of thalidomide with direct antiproliferative and cytotoxic effects on the myeloma tumor cell, as well as antiangiogenic activity and immunomodulatory effects. Together with the introduction of bortezomib and thalidomide, lenalidomide has significantly...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: van de Donk, Niels WCJ, Görgün, Güllü, Groen, Richard WJ, Jakubikova, Jana, Mitsiades, Constantine S, Hideshima, Teru, Laubach, Jacob, Nijhof, Inger S, Raymakers, Reinier A, Lokhorst, Henk M, Richardson, Paul G, Anderson, Kenneth C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2012
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430086/
https://ncbi.nlm.nih.gov/pubmed/22956884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S27087
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia